Going Below the Surface, a National Pharmaceutical Council initiative launched in 2018, in a recent newsletter highlights health care spending issues, including a recent study in JAMA.
The study by Dieleman et. al. breaks down spending data between 1996-2016 by payers and disease conditions.
“Unsurprisingly, the findings show that spending is not distributed equally among public insurance, private insurance and out-of-pocket payments, nor are all conditions created equal when it comes to the U.S. total cost burden,” the newsletter states.
To read more, click here.
Click here to read the study on JAMA. (Paid subscription required)